九洲药业：11月12日召开董事会会议

Group 1 - The core point of the article is that Jiuzhou Pharmaceutical (SH 603456) held its 18th meeting of the 8th board of directors on November 12, 2025, to discuss various proposals, including the election of a director to represent the company in executing its affairs [1] - For the fiscal year 2024, Jiuzhou Pharmaceutical's revenue composition is heavily weighted towards the production and sales of chemical raw materials and intermediates, which account for 98.56% of total revenue, while other businesses contribute only 1.44% [1] - As of the time of reporting, Jiuzhou Pharmaceutical has a market capitalization of 17.7 billion yuan [1]